PDRX Stock Overview

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. More details

PDRX fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 4.7% per year over past 5 years

Does not have a meaningful market cap ($5M)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

PD-Rx Pharmaceuticals, Inc. Competitors

Agape ATP

NasdaqCM:ATPC

US$4.7m

Cosmos Health

NasdaqCM:COSM

US$14.1m

Nowtransit

OTCPK:NOTR

US$41.6m

Kun Peng International

OTCPK:KPEA

US$32.0m

Price History & Performance

Summary of share price highs, lows and changes for PD-Rx Pharmaceuticals
Historical stock prices
Current Share Price	US$3.05
52 Week High	US$6.25
52 Week Low	US$0.000001
Beta	1116519.8
1 Month Change	-15.51%
3 Month Change	-16.44%
1 Year Change	n/a
3 Year Change	22.00%
5 Year Change	-16.44%
Change since IPO	103.33%

Recent updates

Shareholder Returns

	PDRX	US Healthcare	US Market
7D	0%	-1.5%	-2.8%
1Y	n/a	-12.9%	24.1%

Return vs Industry: Insufficient data to determine how PDRX performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how PDRX performed against the US Market.

Price Volatility

Is PDRX's price volatile compared to industry and market?
PDRX volatility
PDRX Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PDRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PDRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1986	n/a	Robert Holsey	www.pdrx.com

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspensions products; and packaging services. It also provides dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescription that are filled onsite.

PD-Rx Pharmaceuticals, Inc. Fundamentals Summary

How do PD-Rx Pharmaceuticals's earnings and revenue compare to its market cap?
PDRX fundamental statistics
Market cap	US$5.02m
Earnings (TTM)	-US$753.49k
Revenue (TTM)	US$18.95m

0.3x

P/S Ratio

-6.7x

P/E Ratio

Is PDRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PDRX income statement (TTM)
Revenue	US$18.95m
Cost of Revenue	US$13.32m
Gross Profit	US$5.62m
Other Expenses	US$6.38m
Earnings	-US$753.49k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.46
Gross Margin	29.68%
Net Profit Margin	-3.98%
Debt/Equity Ratio	0%

How did PDRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 01:30
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PD-Rx Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

PD-Rx Pharmaceuticals OTCPK:PDRX Stock Report